According to MetLife's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.3868. At the end of 2022 the company had a P/E ratio of 14.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 14.2 | 68.33% |
2021 | 8.42 | 1.93% |
2020 | 8.26 | -1.33% |
2019 | 8.37 | 1.5% |
2018 | 8.25 | -41.12% |
2017 | 14.0 | -81.56% |
2016 | 76.0 | 807.11% |
2015 | 8.37 | -0.26% |
2014 | 8.40 | -40.71% |
2013 | 14.2 | 99.32% |
2012 | 7.10 | 57.91% |
2011 | 4.50 | -66.74% |
2010 | 13.5 | -223.83% |
2009 | -10.9 | -247.62% |
2008 | 7.40 | -24.27% |
2007 | 9.77 | 50.32% |
2006 | 6.50 | -6.96% |
2005 | 6.99 | -28.97% |
2004 | 9.84 | -3.29% |
2003 | 10.2 | -4.61% |
2002 | 10.7 | -75.83% |
2001 | 44.1 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.